Your browser doesn't support javascript.
loading
Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma.
Bechter, Oliver E; Dumez, Herlinde; Costermans, Jo; Punie, Kevin; Hsu, Karl; Dedieu, Jean-François; Ghuysen, Anne-Frédérique; Francesconi, Elisa; Sharma, Jyoti; Liu, Li; Schöffski, Patrick.
Afiliação
  • Bechter OE; Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven - University of Leuven, 3000, Leuven, Belgium. oliver.bechter@uzleuven.be.
  • Dumez H; Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven - University of Leuven, 3000, Leuven, Belgium.
  • Costermans J; Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven - University of Leuven, 3000, Leuven, Belgium.
  • Punie K; Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven - University of Leuven, 3000, Leuven, Belgium.
  • Hsu K; Sanofi, Cambridge, MA, USA.
  • Dedieu JF; Sanofi, Chilly-Mazarin, France.
  • Ghuysen AF; Sanofi, Chilly-Mazarin, France.
  • Francesconi E; Sanofi, Vitry-sur-Seine, France.
  • Sharma J; Sanofi, Bridgewater, NJ, USA.
  • Liu L; Sanofi, Bridgewater, NJ, USA.
  • Schöffski P; Department of Oncology, Leuven Cancer Institute, University Hospitals Leuven, KU Leuven - University of Leuven, 3000, Leuven, Belgium.
Cancer Chemother Pharmacol ; 78(1): 83-90, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27169794

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinoxalinas / Sulfonamidas / Linfoma / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinoxalinas / Sulfonamidas / Linfoma / Neoplasias / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article